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ABSTRACT
Obesity is the worst health risk worldwide, which is linked to a number 
of diseases. Pancreatic lipase is considered as an affective cause of 
obesity and can be a major target for controlling the obesity. The 
present study was designed to find out best phytochemicals against 
pancreatic lipase through molecular docking combined with 
molecular dynamics (MD) simulation. For this purpose, a total of 3770 
phytochemicals were docked against pancreatic lipase and ranked 
them on the basis of binding affinity. Finally, 10 molecules (Kushenol K, 
Rosmarinic acid, Reserpic acid, Munjistin, Leachianone G, Cephamycin 
C, Arctigenin, 3-O-acetylpadmatin, Geniposide and Obtusin) were 
selected that showed strong bonding with the pancreatic lipase. MD 
simulations were performed on top five compounds using AMBER16. 
The simulated complexes revealed stability and ligands remained 
inside the binding pocket. This study concluded that these finalised 
molecules can be used as drug candidate to control obesity.
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1. Introduction
Obesity is a term which is described as the accumulation of immense fat in the human body. 
Obesity is the worst health risk worldwide (Sukhdev & Singh 2013). It is commonly described 
by Body mass index (BMI). BMI is the ratio of object’s weight to height (Locke et al. 2015). It 
is a measure commonly used to assess the obesity, if the value of BMI in adults is more than 
30 kg/m2, it means the object is obese. Obesity is a commonly increasing problem around 
the world. The frequency of obesity is 15–20% and 10–15% in women and men, respectively 
(Seidell 2000; Locke et al. 2015). Obesity is a health risk which is attached with a number of 
diseases like dyslipidemia, sleep apnoea (Sukhdev & Singh 2013), diabetes mellitus (Archana 
et al. 2010), hypertension (Vaněčková et al. 2014) and heart disease (Bastien et al. 2014; Lavie 
et al. 2014; Nakamura et al. 2014). According to the WHO survey there were 1.9 billion over-
weighted, 41 million children under the age of 5 and 600 million adults were obese in 2014. 
Main cause of obesity is imbalance between energy intake and use (Lavie et al. 2014). Less 
physical activity, overeating and intake of food which is rich in dietary fat are the main reasons 
for obesity.
Pancreatic lipase is an enzyme which is produced in pancreas and secreted into the intes-
tine. Pancreatic lipase converts triglycerides into fatty acids and therefore it is considered as 
an affective cause of obesity (Mukherjee & Sengupta 2013). Pancreatic lipase can be a major 
target for controlling the obesity because it has a vital role in increasing the body weight.
Thousands of plants and their extracts are used as a source of medicine. Number of phy-
tochemicals are characterised and separated from different plant sources such as saponins, 
flavonoids, flavonols and alkaloids. Phytochemicals may act as good anti-obesetic agents 
by minimising the absorption of lipids and energy intake from food and by increasing the 
use of energy by degrading the fat which is stored in the human body (Sukhdev & Singh 
2013; Mukherjee et al. 2015; Masmoudi-Allouche et al. 2016). Therefore, this study is con-
ducted to increase the range of pancreatic lipase inhibitors which has fewer side effects as 
compared to ‘Orlistat’.
2. Results and discussion
Pancreatic lipase structure was taken from PDB and optimised with the help of MOE. 
Pancreatic lipase was docked against a library of ligand molecules. MOE sorted the result by 
docking score and gave the possible confirmations for each ligand molecule. Top confirma-
tions of each ligand molecule were further analysed and were used to check the interactions 
with the target protein. Ten molecules were finalised based on their binding affinities and 
drug-likeness screening. Pubchem_ID, docking score, root mean square deviation values 
and residues of target molecule which interact with the ligand molecule are given in 
(Table 1)). Further, 20 ns MD simulations were performed for the five top-ranked complexes 
to check the stability of protein’s back bone and to understand the interacting behaviour of 
the ligand after simulation.
2.1. Molecular docking studies
Orlistat is a drug which acts as a lipase inhibitor and mainly used as an anti-obesitic agent. 
It plays a major role in controlling the obesity and was used as a reference drug in the current 
study Molecular weight of kushinol K is 472.534 g/mol. It contains five hydrogen bond donors 
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and eight hydrogen bond acceptors. It showed strong bonding and less docking score 
(−13.78 kcal/mol) as compared to the reference drug (−10.2014 kcal/mol). It also showed 
strong interactions with the different residues of target molecule i.e. Ser152, Arg256 and 
Asp79 within the same pocket, where reference drug bound as shown in (Figure 1). All other 
selected molecules shown in Table 1 had significant binding potential as well as less docking 
score, from −13.55 to −12.02 kcal/mol, as compared to the reference drug. Interactions of 
selected molecules are shown in (Figure 1) and strong binding modes of selected phyto-
chemicals with the target molecule are given in (Figure 2).
In a recent study, it has been reported that chlorophyll a, Isofucosterol and Saringosterol, 
found in Sargassum thunbergii, act as potential inhibitors of pancreatic lipase (Kim et al. 
2014). Docking score and interaction study of the reported compounds have been compared 
with the compound proposed in present study which indicated that, compounds reported 
in current study show a strong interaction with the pancreatic lipase as compared to the 
already reported molecules.
2.2. Drug-like properties
Drug scan was performed to assess the drug-like properties of all the finalised phytochem-
icals. Lipinski’s Rule of Five was used as a standard. This rule explains the different properties 
of a drug molecule as well as its interactions metabolism within the human body as well as 
its excretion. Drug-like properties of all the finalised molecules, as well as reference drug, 
are given in (Table S1). All the selected molecules of this study followed the rule and showed 
all those properties which a drug should contain.
2.3. Molecular dynamics simulation studies
For the current study, only the top-ranked compounds that predicted binding affinities lower 
than -13 kcal/mol were taken in consideration for 20 ns all-atom backbone simulation. These 
include; Kushenol K, Rosmarinic acid, Reserpic acid, Munjistin and Leachianone G. All these 
compounds were found to remain inside the binding pocket throughout MD simulation. 
For all complexes, the computed root-mean-square-deviation (RMSD) using allbackbone 
atoms on initial minimised docked complex were found to be less than 1.5Å, 2.5Å, 2.25Å, 
1.5Å and 2Å against Kushenol K, Rosmarinic acid, Reserpic acid, Munjistin and Leachianone 
Table 1. docking results of top 10 molecules and control drug are given here. ser 152 is highlighted in 
red which indicates that all the selected molecules interact with it just like orlistat.
Sr_NO Pubchem_ID Docking score RMSD refine Interacting residues
1 44,428,630 −13.7835 1.1342 ser152, arg256, asp79
2 5,281,792 −13.5563 1.0924 ser152, tyr114, Phe215, his263
3 65,747 −13.2923 1.1394 ser152
4 160,476 −13.2506 1.2199 ser152, Phe215, tyr114, his263
5 5,275,227 −13.1246 1.4942 ser152, asp79, arg256, his151, his263
6 155,380 −12.8606 1.8984 ser152, arg256, Phe77, Phe215, his263
7 107,848 −12.5235 1.2337 ser152, Phe77, Phe215, his151, his263
8 441,084 −12.3431 2.0383 ser152, Phe215, lle78
9 64,981 −12.1382 1.3025 ser152, his263
10 10,406,203 −12.0290 0.9371 ser152, his263
11 orlistat(ref) −10.2014 3.5768 ser152
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G, respectively (Figure S1). Less deviation from the initial structure showed that the simulated 
system was well equilibrated. Also, there were less than 0.5Å deviations with all the five 
compounds which were in consensus with the initial conformation and these ligands 
remained inside the binding pocket throughout the 20 ns simulation. While, Kushenol K, 
Munijistin and Leachianone complexed with pancreatic lipase were found to be more stable 
as the RMSD of protein’s backbone remained to converge between 1–1.5Å, 0.7–1.4Å and 
1.5–2Å, respectively. To analyse per residue fluctuations, average root-mean-square-fluctu-
ations (RMSF) for each residue throughout simulations are displayed in Figure S2. It can be 
seen that no big fluctuations are reported, except few with no greater than 2.5Å because of 
the presence of flexible loops in that particular region of pancreatic lipase. Importantly, the 
binding site residues (Phe77 – Ser152) only fluctuated less than 0.75Å i.e. Ser 152, which was 
key residue in interaction with all ligands. Apparently to Rosamarinic acid and Resperpic 
complexes which fluctuated prominently (in orange and red) based on their RMSD deviation 
plots, Kushenol K (black), Munjistin (Indigo)and Leachianone (Cyan) showed fewer 
fluctuations.
Figure 1. Interactions of first five finalised molecules and control drug with pancreatic lipase are shown 
in this figure. Interacting residues of receptor with ligand molecules are shown with the help of arrows. 
Green arrows indicating the side chain acceptors and donors while blue arrows representing the backbone 
acceptors and donors.
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In summary, our findings reported that Kushenol K with few other compounds showed 
strong hydrogen bonding and hydrophobic interactions as compared to the reference drug 
and possessed necessary drug-likeness properties. Furthermore, pancreatic lipase complexed 
with top compounds remained stable throughout 20 ns MD simulations. Present findings 
will have a decisive role whether these compounds have the potential to be developed into 
an effective oral therapeutic inhibitors against pancreatic lipase to control obesity after 
testing through in vitro and in vivo experiments.
3. Experimental
Docking was performed between the target enzyme known as pancreatic lipase and a library 
of 3770 bioactive compounds with the help of MOE. Top-ranked complexes were then used 
to perform MD simulation to check the overall stability of binding pose and protein’s 
backbone.
Figure 2. Binding modes of top five finalised molecules and control drug within the pocket of pancreatic 
lipase. Green surface representing the binding pocket of the receptor, while phytochemicals are shown 
in ball and stick format.
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3.1. Tools and databases used
Following tools and databases were used in this present study
Molecular operating Environment (MOE, Roy & Luck 2007), Protein Data Bank (PDB, 
Berman et al. 2000), Pubchem (Wang et al. 2009) and AMBER16 for MD simulations (Maier 
et al. 2015)
3.2. Preparation of target and ligand molecules
PDB file of pancreatic lipase was downloaded from the PDB (PBD ID: 1LPA). Co-crystallised 
ligand molecules, metal atoms and water molecules were removed with the help of MOE. 
Standard protocol of MOE was used to minimise energy and to set the protonation states. 
A total of 3770 bioactive molecules belong to the different classes of phytochemicals were 
taken from the Pubchem. All these molecules were stored in a single database after per-
forming energy minimisation.
3.3. Molecular docking
Binding pockets were found with the help of site finder tool of MOE. Before virtual screening, 
a simple redocking procedure of co-crystallised ligand on the selected protein to check the 
reliability of scoring function of docking algorithm used. Top conformations were selected 
on the basis of energy and docking score for further analysis.
3.4. Drug scan
After the step of molecular docking, drug-like properties of ligand molecules were checked 
using the drug scan tool to ensure that the finalised molecules follow the Lipinski’s Rule of 
Five.
3.5. Molecular dynamics simulation
MD simulations of 20 ns were performed to check the pancreatic lipase backbone stability 
with top ranked selected ligands using AMBER 16.0 software package (Case et al. 2014). 
Amber ff14SB force fields (Maier et al. 2015) were used to describe proteins counter ions and 
water. Antechamber programme was employed to generate force field parameters for ligands 
using AMBER force field (GAFF) using the Antechamber programme. The tleap module was 
used to produce all essential parameters by considering residues at their default protonation 
states at neutral pH value. Prior to energy minimisation, all complexes were neutralised by 
adding Na + ions around the complex at different locations and centred in a truncated octa-
hedron box with a distance of 10Å from the edge of the box, and solvated using TIP3P water 
molecules. The particle mesh Ewald method with a non-bounded cut-off of 10Å was used 
to set the periodic boundary conditions. Integration step at 2 fs was set and the SHAKE was 
employed to constrain X–H bond lengths involving hydrogen bonds. The system and counter 
ions, water simulated underwent minimisation using 5000 steps of steepest descent method 
followed by conjugate gradient method. Then system was gradually heated from 0 to 300 K 
with 50 ps and maintained at 300 K with restraints on the complex. After heating, the system 
was equilibrated for 500 ps and finally, a 20 ns of a relaxed MD production run was performed 
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using constant pressure (p = 1.0 atm) and temperature (T = 300 K). Coordinate trajectories 
were collected after every 2 ps for the whole production run and CPPTRAJ modules of AMBER 
16 were implied for trajectories analyses (Roe & Cheatham 2013).
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